Clarivate (NYSE:CLVT - Get Free Report) updated its FY25 earnings guidance on Wednesday. The company provided EPS guidance of $0.60-$0.70 for the period, compared to the consensus EPS estimate of $0.73. The company issued revenue guidance of $2.28-$2.40 billion, compared to the consensus revenue estimate of $2.53 billion. Clarivate also updated its FY 2025 guidance to 0.600-0.700 EPS.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on CLVT. William Blair cut Clarivate from an "outperform" rating to a "market perform" rating in a report on Wednesday, November 6th. Barclays lowered their price target on Clarivate from $5.00 to $4.00 and set an "underweight" rating on the stock in a report on Thursday, November 7th. Finally, Royal Bank of Canada reissued a "sector perform" rating and set a $6.00 price target on shares of Clarivate in a report on Thursday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $7.10.
Check Out Our Latest Stock Report on Clarivate
Clarivate Stock Performance
Clarivate stock traded up $0.01 during trading on Friday, reaching $4.85. The company had a trading volume of 8,817,103 shares, compared to its average volume of 5,505,494. Clarivate has a 52 week low of $4.22 and a 52 week high of $9.07. The firm's 50-day simple moving average is $5.12 and its 200 day simple moving average is $5.79. The firm has a market capitalization of $3.44 billion, a price-to-earnings ratio of -5.05 and a beta of 1.17. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.84.
Clarivate declared that its Board of Directors has approved a share buyback program on Monday, December 16th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 12.8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's board believes its shares are undervalued.
About Clarivate
(
Get Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Articles
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
